Remember, the cheap study always finds a way to bill you twice. Go break some eggs.
Your Weekly Briefing:
👀 Insights
The Clinical Trial You Run, Is the One Your Tox Study Allows
Most founders think they design their Phase 1 trial when they write the clinical protocol.
They don't. The fence — how long you can dose, how high you can push, what you're allowed to claim — went up months earlier, in a tox study that wrapped before the protocol existed.
This week's piece breaks down the four study-design choices that quietly set your clinical borders, and what each one costs to get wrong.
Toxicology studies play a bigger part in designing clinical trials than you might think. Find out why on this week's edition of The Nonclinical.
💭 Myths v. Realities
Myth: GLP means good science.
Reality: GLP is a documentation standard, not a quality-of-science standard. It governs how you record and verify what you did — not whether the study was designed well. A perfectly GLP-compliant study with the wrong doses, wrong species, or wrong endpoints is still a useless study.
🔧 Tools
🤑 Executive tier now has a payment plan option!
If you’ve been wanting all the things the Executive tier has to offer — private Slack, monthly Office Hours, direct access to me — but have trouble with the cost, I’ve just opened a payment plan option.
$200/month for 5 payments. And you get it all from Day 1.
(still need help? reply to this email, I will work with you)
Get the Executive tier with 5 payments of $200/month. Check out the Free Preview today.